An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells. (2022)

First Author: Broadbent L
Attributed to:  Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0266412

PubMed Identifier: 35436306

Publication URI: http://europepmc.org/abstract/MED/35436306

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 4

ISSN: 1932-6203